New Assassin’s Creed Game Reportedly in Trouble, Could Be Cancelled

Ubisoft’s standalone Assassin’s Creed multiplayer project, Project Invictus, is reportedly drawing very poor internal playtest feedback, with one April 30 session described as "awful." The game is still thought to target a late 2026 release, but reports suggest it could face a major delay or even be scrapped. The news adds to Ubisoft’s recent string of multiplayer disappointments and weakens sentiment around the Assassin’s Creed franchise expansion strategy.

Analysis

This is less a near-term revenue event than a signal that Ubisoft’s optionality strategy is wobbling. A standalone multiplayer spinoff was meant to extend monetization of the AC IP without cannibalizing the core single-player cadence; if the multiplayer layer is failing in playtest, that usually implies either a weak product loop or an unfocused target audience, both of which raise the probability of sunk development costs with little offsetting live-service upside. The market should care less about this specific title’s unit sales and more about the read-through that Ubisoft still has trouble building durable evergreen engagement outside its legacy formula.

The second-order effect is cannibalization risk inside the broader AC roadmap. If the multiplayer concept is perceived internally as brittle, management may reallocate talent and marketing bandwidth toward higher-confidence launches, which can create execution slippage elsewhere and compress the release window for franchise expansion bets. That matters because Ubisoft’s multiple has historically depended on evidence of recurring monetization; a public stumble here reinforces the view that the company remains a content producer, not a platform operator.

The bearish setup is mostly medium-dated: months, not days. Early playtest weakness can still be reversed, but only if Ubisoft rapidly tightens the core loop and changes the game’s positioning; otherwise the most likely outcome is delay, scope reduction, or quiet cancellation, each of which damages investor confidence more than the direct P&L impact. The contrarian angle is that this could actually be mildly positive for capital allocation if management avoids forcing a bad launch; preserving development resources for higher-probability AC titles may improve overall franchise ROI, but that benefit is hard to see before it appears in guidance.

On balance, the bigger issue is sentiment and credibility. Ubisoft has now accumulated enough evidence of multiplayer misfires that investors may start discounting any new live-service initiative until post-launch retention metrics prove otherwise, which can cap any rerating from future announcements. If the company can’t demonstrate stronger internal test scores by the next update cycle, the market will likely price in another write-down-style overhang rather than a growth catalyst.

Key Decisions for Investors

• Short UBSFY/UBSFY US ADR on strength into any AC-related hype; 1-3 month horizon. Risk/reward favors a 1-2 turn downside re-rating if the market starts pricing delay/cancellation odds higher.
• Buy short-dated Ubisoft downside via puts if liquid enough around the next product/update window; structure for a 2-4x payoff if management signals scope cuts or delays, with defined premium risk.
• Pair trade: short Ubisoft against long a higher-quality European game publisher with better live-service execution (e.g., long Embracer-less, quality-adjusted peer exposure via sector basket). The spread benefits if the market distinguishes execution risk from IP strength.
• Avoid chasing any positive headline until there is evidence of retention, not just playtest fixes. For investors already long, use rallies to trim: the asymmetry is poor if the next catalyst is another delay rather than launch traction.